J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr

The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.

GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr

The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.

Sun Pharmaceutical Q3FY21 net profit at Rs. 1852.48 Cr

The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.

Divya Dhankhar joins Gilead Sciences as Director – Global Digital Innovation & AI

Divya brings a strong track record of delivering technology-led transformation across the pharmaceutical industry

India's clinical research ambitions need more than regulatory reforms: Experts

At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust

India to launch revamped Anemia Mukt Bharat Abhiyaan with expanded 7x7x7 strategy

The transition of the existing Anemia Mukt Bharat programme into Anemia Mukt Bharat Abhiyaan signals a shift towards a more comprehensive, technology-enabled and community-driven approach

Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr

The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside

Efzimfotase alfa shows strong Phase III results in pediatric hypophosphatasia trial

The study also met its key secondary endpoint for bone health

Sanofi Foundation doubles down on children and youth with €15 milliion annual push

The Foundation says it is working alongside NGOs, healthcare professionals, patient groups, and local communities to build programs

PeptiStar tests Asahi Kasei’s heat-free system to speed up API manufacturing